MLTX
Price
$61.99
Change
+$5.61 (+9.95%)
Updated
Sep 26 closing price
Capitalization
3.94B
52 days until earnings call
RAPP
Price
$26.59
Change
+$1.62 (+6.49%)
Updated
Sep 26 closing price
Capitalization
1.23B
40 days until earnings call
Interact to see
Advertisement

MLTX vs RAPP

Header iconMLTX vs RAPP Comparison
Open Charts MLTX vs RAPPBanner chart's image
MoonLake Immunotherapeutics
Price$61.99
Change+$5.61 (+9.95%)
Volume$1.15M
Capitalization3.94B
Rapport Therapeutics
Price$26.59
Change+$1.62 (+6.49%)
Volume$1.13M
Capitalization1.23B
MLTX vs RAPP Comparison Chart in %
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. RAPP commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and RAPP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (MLTX: $61.99 vs. RAPP: $26.59)
Brand notoriety: MLTX and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 195% vs. RAPP: 133%
Market capitalization -- MLTX: $3.94B vs. RAPP: $1.23B
MLTX [@Biotechnology] is valued at $3.94B. RAPP’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while RAPP’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 5 bearish.
  • RAPP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а +15.27% price change this week, while RAPP (@Biotechnology) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

RAPP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.94B) has a higher market cap than RAPP($1.23B). RAPP YTD gains are higher at: 49.887 vs. MLTX (14.478). RAPP has higher annual earnings (EBITDA): -100.79M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. RAPP (260M). RAPP has less debt than MLTX: RAPP (11.9M) vs MLTX (75.8M). MLTX (0) and RAPP (0) have equivalent revenues.
MLTXRAPPMLTX / RAPP
Capitalization3.94B1.23B321%
EBITDA-196.98M-100.79M195%
Gain YTD14.47849.88729%
P/E RatioN/A22.16-
Revenue00-
Total Cash425M260M163%
Total Debt75.8M11.9M637%
TECHNICAL ANALYSIS
Technical Analysis
MLTXRAPP
RSI
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEQAX17.260.16
+0.94%
ICON Equity Income Investor
TFIFX48.750.35
+0.72%
T. Rowe Price Financial Services I
PYODX47.020.29
+0.62%
Victory Pioneer Y
STCZX18.100.06
+0.33%
Virtus Silvant Large-Cap Growth Stk R6
CAHEX18.780.05
+0.27%
Calamos Hedged Equity A

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+9.95%
XNCR - MLTX
49%
Loosely correlated
+12.00%
NUVL - MLTX
48%
Loosely correlated
+4.99%
AURA - MLTX
44%
Loosely correlated
+4.76%
NRIX - MLTX
44%
Loosely correlated
+7.20%
XENE - MLTX
43%
Loosely correlated
+4.00%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+6.49%
NEVPF - RAPP
45%
Loosely correlated
N/A
FTRE - RAPP
35%
Loosely correlated
-2.69%
PRAX - RAPP
35%
Loosely correlated
+6.48%
MLTX - RAPP
35%
Loosely correlated
+9.95%
DNLI - RAPP
32%
Poorly correlated
+3.87%
More